Fda Johnson Johnson
-
FDA warns Johnson & Johnson COVID-19 vaccine linked to rare neurological reactionThe FDA flagged reports of Guillain-Barre syndrome, an immune system disorder that can cause muscle weakness and occasionally paralysis.WorldJul 12, 2021
-
U.S. authorizes 14M more J&J COVID-19 vaccine doses from Baltimore factory: reportAll the J&J doses authorized from the plant to date are expected to be exported to other countries, one of the sources said.HealthJun 16, 2021
-
U.S. to resume using J&J COVID-19 vaccine after CDC recommends ending pauseThe panel last week called for more data about a possible link to rare blood clots in the brain before deciding how and whether to end a "pause" of the COVID-19 vaccine.WorldApr 23, 2021
![]()
